Skip to main content
Irfan Qureshi, MD, Neurology, Bronx, NY, Burke Rehabilitation Hospital

IrfanAQureshiMD

Neurology Bronx, NY

Assistant Professor, Neurology, Albert Einstein College of Medicine

Are you Dr. Qureshi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 52 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Irfan Qureshi, MD is a board certified neurologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with Burke Rehabilitation Hospital and is an Assistant Professor at Albert Einstein College of Medicine.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2003 - 2006
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 2002 - 2003
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2002

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2025
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • Biohaven's Phase 3 Trial, and Other News: The Good, Bad and Ugly of Biopharma
    Biohaven's Phase 3 Trial, and Other News: The Good, Bad and Ugly of BiopharmaJuly 22nd, 2020
  • Biohaven's Verdiperstat, an Oral Myeloperoxidase Inhibitor, Selected for Platform Trial Collaboration at Massachusetts General Hospital's Healey & AMG Center for Amyotrophic Lateral Sclerosis (ALS)
    Biohaven's Verdiperstat, an Oral Myeloperoxidase Inhibitor, Selected for Platform Trial Collaboration at Massachusetts General Hospital's Healey & AMG Center for Amyotrophic Lateral Sclerosis (ALS)January 22nd, 2020
  • Biohaven Provides Update on Phase 2/3 Alzheimers Disease Clinical Trial: Over 400 Patients Enrolled
    Biohaven Provides Update on Phase 2/3 Alzheimers Disease Clinical Trial: Over 400 Patients EnrolledAugust 12th, 2019
  • Join now to see all

Hospital Affiliations